
CryoEM_2_Johan_Spinnell-1024×683
Antimicrobial resistance the subject of the first InfraLife workshop

Antimicrobial resistance the subject of the first InfraLife workshop
Research and Infrastructure is a priority area in the Swedish Life Science strategy. InfraLife aim to increase the use of Swedish research infrastructures, broaden the user base to represent a range of stakeholders and stimulate cross-sectoral collaboration, to address some of today’s grand challenges.
These challenges require a collaborative and cross-disciplinary approach – where InfraLife aims to serve as a hub connecting stakeholders, displaying the potential of the advanced technologies and making these unprecedented tools accessible to be utilized in addressing complex research questions.
The InfraLife Hub aims to improve the knowledge, availability and user base of unique technologies and services offered by the three infrastructures. It will also create opportunities for tech development, transfer and innovation with industry.
InfraLife is a four-year project with the large-scale research infrastructures SciLifeLab, MAX IV and ESS, also partnering with industrial organizations SwedenBIO & LIF and in collaboration with SWElife, MedTech4Health and Swedish MedTech.
The project is funded by the Swedish Research Council and aims to increase knowledge and facilitate infrastructure access across sectors such as academia, industry, and health care. By doing so, InfraLife intends to stimulate cross-sectorial collaborations advancing science utilizing the infrastructures, to enable the life science industry and healthcare sector to benefit from research infrastructure, and to create relevant data support and structures.
The first InfraLife workshop addresses antimicrobial resistance
The first InfraLife workshop gathers stakeholders in the field of antimicrobial resistance (AMR) for a joint discussion on 2 June, 2021, 9:00-13:00. Organised by SciLifeLab, MAXIV, ESS, SwedenBIO, LIF, SWElife, MedTech4Health.
Antimicrobial resistance is a major health threat and resistance to common antibiotics is estimated to cause 700,000 deaths each year globally. There is a strong need for new antimicrobials, but also for better diagnostics and non-antibiotic methods to advance the development of new strategies against AMR.
AKTUELLT
Ny projektansökningsomgång i AIDA
AIDA är en nationell arena för forskning och innovation inom AI för medicinsk bildanalys. Inom AIDA finns det flera möjligheter till projektstöd.
What role is medical technology given in the new Life Science Strategy?
During Medicinteknikdagarna, Medtech4Health will focus on the national Life Science Strategy and the Research and Innovation Bill. What place will medical technology occupy, and how do we move from strategy to action?
Medtech4Health Innovation Award celebrates ten years – time to nominate your contribution
For a decade, Medtech4Health has been recognizing medical technology projects that make a real difference for patients, relatives, and staff. Now it's time once again to crown a winner in the Medtech4Health Innovation Award 2026.
From Sweden to Europe: AIDA inspires internationally
Health data is becoming increasingly important for the development of healthcare. Internationally, health and research data is used to improve treatments, refine diagnostics, and accelerate innovation.
NYHETSBREV
Följ nyheter och utlysningar från Medtech4Health – prenumera på vårt nyhetsbrev.

AKTUELLT
Vilken roll ges medicintekniken i den nya Life science-strategin?
Under Medicinteknikdagarna sätter Medtech4Health fokus på den nationella Life science-strategin och forsknings- och innovationspropositionen. Vilken plats får medicintekniken, och hur går vi från strategi till verkstad?
Missa inte rabatten till Framtidens hälsa och sjukvård
Medtech4Health är samarbetspartner till evenemanget vilket ger dig 50 procents rabatt på både tvådagars- och endagsbiljetter.
Ny studie kartlägger behovet av samordnad patientsamverkan
Nu finns en ny studie om en nationell samordning och matchning för patientinvolvering i utvecklingen av medicinteknik. Studien har gjorts av Eupati Sverige med finansiering av bland andra Medtech4Health.
Från Sverige till Europa: AIDA inspirerar internationellt
Hälsodata får allt större betydelse för utvecklingen av hälso- och sjukvården. Internationellt används hälso- och forskningsdata för att förbättra behandlingar, finslipa diagnostiken och påskynda innovation.
NYHETSBREV
Följ nyheter och utlysningar från Medtech4Health - prenumera på vårt nyhetsbrev.